9 Comments
May 3, 2022Liked by John Skylar, PhD

In further news on my participation in the Pfizer omicron-specific trial, at my three-month visit last week following my booster that was either the omicron vaccine or the original, I was unblinded, and offered another booster, which was definitely the omicron-specific vaccine. I had been in the control group, and had received the original vaccine. I'll be giving them some more blood tomorrow, one week after my omicron-specific booster. This is the first time they've wanted blood so soon after the shot. Previously, it has always been one-month after the shot. The staff mentioned that there are a bunch of sub-studies they're keeping track of.

Expand full comment

Thanks for the lesson on statistics and the skew in the Lancet article! However, I have to say that I thought the point of the Lancet article was to produce data on how the efficacy of the vaccines waned over time. Given that fact I thought 50% was pretty good given the variable efficacy of the flu shot from year to year!

Expand full comment

"Last issue sparked some really interesting discussion about antivirals, and also about progress towards approval of a pediatric vaccine. I recommend going back and reading those discussions!" Except ... look down below. That article is not linked from this one, for whatever reason.

Expand full comment

I got a notification of one of those nonsense-spewing comments, but by the time I clicked on the link in the email, you had already deleted it.

Expand full comment